EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography.Part 2: Clinical Applications

By D. Cosgrove, F. Piscaglia, J. Bamber, J. Bojunga, J. Correas, O. Gilja, A. Klauser, I. Sporea, F. Calliada, V. Cantisani and 11 more. Ultraschall in der Medizin, 2013

983 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Epidemiology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/e247037e7f0ef65765a944b36a8237500c59b9a3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

1. Mark L. Palmeri
2. Kathryn Nightingale
3. Mickaël Tanter
4. Mathias Fink

In Epidemiology

1. M. Kudo
2. Laurent Castéra
3. Asociacion Latinoamericana para el Estudio del Higado

In Radiology, Nuclear Medicine and Imaging

1. Mark L. Palmeri
2. Kathryn Nightingale
3. Mathias Fink
4. Mickaël Tanter
5. Gregg E. Trahey

Citations in the corpus

• Ultrasound Elastography: Review of Techniques and Clinical Applications (2017, methodology): “Since in 1D-TE excitations are applied at the skin surface, it is limited by patient obesity, narrow intercostal spaces and the presence of perihepatic ascites [19].”
• WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver. (2015, background): “The European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) has recently issued guidelines and recommendations on the clinical use of ultrasound elastography (Bamber et al. 2013; Cosgrove et al. 2013).”
• The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version) (2018, positive): “…z ed d i s t r i bu t i on i s s t r i c t l y p r oh i b i t ed . based technique [309] complementary to B-mode EUS and possibly EUS-elastography [310] to differentiate solid appearing structures, to characterize mass lesions, to improve staging of gastrointestinal and pancreatobiliary cancer…”